Pfizer said on Tuesday its experimental obesity drug, which it acquired through the Metsera deal, showed up to 12.3% weight ...

Pfizer CEO Albert Bourla criticizes RFK's vaccine stance, warns US health research is losing ground to China, and urges ...

Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing Pfizer (PFE.N), opens new tab access to its technology that boosts immune responses to vaccines ‌for use in up to ...

Billionaire entrepreneur Elon Musk is combining his rocket company SpaceX with his artificial intelligence startup xAI, he announced yesterday. The tie-up comes ahead of what's expected to be a huge ...

PepsiCo (NASDAQ:PEP) executives used the company’s fourth-quarter 2025 earnings Q&A session to outline plans to accelerate ...

Promising clinical results in 2026 could set the stage for Pfizer's stock to rebound. However, the company's COVID-19 product and patent cliff challenges could prevent a big bounce this year. Even if ...

Pfizer is penning a cancer discovery pact with Cartography Biosciences that could max out at $865 million biobucks. The Big Pharma is offering the California biotech up to $65 million in upfront, near ...

I last covered Pfizer Inc. stock (PFE) on Nov 8, 2025, with an article titled "Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer". The article mainly served as a review for the company's FQ3 ...

The likes of Pfizer and Merck are facing looming patent cliffs which will expose $400 bln of sales to cheaper competition. To avoid a steep income decline, many will have to splurge on budding ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The South San Francisco company ...

Disney is naming parks chief Josh D’Amaro as its next CEO, succeeding Bob Iger. D’Amaro has served as Disney Experiences ...